Navigation Links
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
Date:8/20/2009

A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

Jacksonville, Fla. (Vocus) August 20, 2009 -- A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

"I am gratified that the truth may finally be coming to light," said C.W.Randolph, Jr., M.D., "Even after the 2002 National Institutes of Health, Women's Health Initiative Trial (WHI) irrefutably established that synthetic hormones (such as the popularly prescribed Premarin family of products) caused the risk of breast cancer to increase 26 percent, physicians continued to prescribe these drugs putting millions of women's lives in jeopardy. Why? Because they were misled by pharmaceutical-sponsored medical studies skewing the facts."

According to Dr. Randolph, a nationally recognized medical expert in the field of natural, or Bioidentical Hormone Replacement Therapies (BHRT), this type of evidence has existed for decades.

As early as 1941, Edgar Allen, M.D., Chair of Yale Medical School Anatomy Department, published an article in the medical journal Cancer Research on the propensity of estrogen to cause cancer in animals. Since that time, the output of medical research and clinical studies continued to mount until, in 2001, representatives from the National Cancer Institute and the National Institutes of Health (NIH) voted 8-1 to add synthetic estrogen to the nation's list of cancer-causing agents.

Recent revelations that Wyeth directed DesignWrite medical ghostwriters to deliberately deemphasize the links between synthetic hormone replacement therapies and breast cancer in published medical journals are bringing experts in the field of BHRT to answer the question of the purpose for manipulating this data.

''Because there is big money at stake,'' says Genie James, M.M.Sc., Executive Director of the Natural Hormone Institute. ''Prior to the WHI findings being made public in 2002, the Premarin-family of products was a 2.2 billion dollar pipeline.''

According to an article in The New York Times, since 2002, sales for Wyeth's Premarin family of products have plummeted 50 percent, and have continued to decline over the last several years.

Research in the U.S. and around the world supports BHRT as the treatment of choice for menopausal symptoms and conditions of hormone imbalance.

"The sad reality is that when marketing gets ahead of medical science, women's lives are put at risk," says James.

About C.W. Randolph, Jr., M.D.: Randolph is an internationally renowned expert in the field of bio-identical hormone replacement. He is a board-certified obstetrician and gynecologist who practiced as a compounding pharmacist. He is the co-founder of the Natural Hormone Institute, a Diplomat of the American Board of Holistic Medicine, and a member of the International Academy of Compounding Pharmacists. He coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

About Genie James, M.M.Sc.: Genie is nationally acknowledged as a change-agent for improved women's health. She is the co-founder and executive director of the Natural Hormone Institute. She coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

Media Contact
Nanette Noffsinger
Burke Hollow Media
(615) 776-4230
nanette(at)burkehollowmedia(dot)com

###

Read the full story at http://www.prweb.com/releases/Breast_Cancer/Synthetic_Hormones/prweb2777324.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
2. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
3. Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
4. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
5. The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin
6. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain
7. ReGen Biologics Clarifies Recent Press about the Menaflex Device
8. Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
9. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
10. Recently Released Data from the National Survey of Childrens Health Reports That Autism Now Affects 1% of Children and is More Common Than Childrens Cancer, Diabetes, and AIDS Combined.
11. American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
Breaking Medicine Technology: